References
- Nanda N, Bao M, Lin H, Clauser K, Komuves L, Quertermous T, et al. Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact- induced activation. J Biol Chem. 2005;280:24680–24689.
- Kauskot A, Di Michele M, Loyen S, Freson K, Verhamme P, Hoylaerts MF. A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1. Blood. 2012;119:4056–4065.
- Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, et al.Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nature genet. 2010;42:608–613.
- Lewis JP, Ryan K, O’Connell JR, Horenstein RB, Damcott CM, Gibson Q, et al. Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes. Circ Cardiovasc Genet. 2013;6:184–192.
- Xiang Q, Cui Y, Zhao X, Zhao N. Identification of PEAR1 SNPs and their influences on the variation in prasugrel pharmacodynamics. Pharmacogenomics. 2013;14:1179–1189.
- Williams JM, Johnson AC, Stelloh C, Dreisbach AW, Franceschini N, Regner KR, et al.Genetic variants in arhgef11 are associated with kidney injury in the dahl salt-sensitive rat. Hypertension. 2012;1157–1168.
- Aird WC. Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms. Circ Res. 2007;100: 158–173.
- Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 2001;19:1349–1358.
- Li Y, Zagato L, Kuznetsova T, Tripodi G, Zerbini G, Richart T, et al.Angiotensin-converting enzyme I/D and α-adducin Gly460Trp polymorphisms. From angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension. 2007;49:1291–1297.
- Kuznetsova T, Staessen JA, Kawecka-Jaszcz K, Babeanu S, Casiglia E, Filipovsky J, et al. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit. 2002;7:215–224.
- Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, et al. Fatal and nonfatal outcomes, incidence of hypertension and blood pressure changes in relation to urinary sodium excretion in White Europeans. JAMA. 2011;305:1777–1785.
- Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al.Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension. J Hypertens. 2009;27:1719–1742.
- Vandenbriele C, Kauskot A, Luttun A, Jassens S, Hoylaerts M, Verhamme P. Platelet endothelial aggregation receptor-1 is a critical determinant of endothelial cell function. Circulation. 2012;126:A11115.
- Regner KR, Harmon AC, Williams JM, Stelloh C, Johnson AC, Kyle PB, et al.Increased susceptibility to kidney injury by transfer of genomic segment from SHR onto Dahl S genetic background. Physiol Genomics. 2012;44:629–637.
- Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kidney Dis. 1995;25:207–221.